Weight loss post deep brain stimulation to bilateral subthalamic nuclei in a Parkinson’s disease with PARKIN mutation – A Harbinger sign of malignancy
Objective: We present a challenging case of genetic PD who presented with progressive weight loss and constipation despite post-DBS and was found to have malignancy.…Bodily Maps of Symptoms and Emotions in Dystonia
Objective: To investigate symptom- and emotion-related sensations in dystonia. Background: Dystonia is a chronic movement disorder characterized by excessive muscle activity leading to involuntary movement…Psychometric Properties of the SCOPA-Cog Turkish version
Objective: The objective of this study is to adapt SCOPA-COG for Turkish-speaking patients with Parkinson's disease, ensuring it is both valid and reliable. This will…Fatigue In Parkinson’s Disease: Is It Primary or Secondary?
Objective: The aim of this study was to investigate whether fatigue in idiopathic Parkinson's disease is primary or secondary and to explore its correlation with…Nutrition, Motor And Non-Motor Symptoms Impact On Life’s Quality In Parkinson’s Disease In Second-Line Therapies
Objective: Analyze the nutritional status, motor and non-motor symptoms of patients with Parkinson´s disease (PD) with second-line therapies [levodopa carbidopa intestinal gel (LCIG) and deep…Variations of Self-Perceived Cognitive Changes by Ethnicity in Parkinson’s Disease Patients
Objective: To study perceptions of cognitive function across ethnic groups by comparing a subjective rating with an objective assessment for patients with PD (PWP). Background:…Individuals With a History of Traumatic Brain Injury Have a Higher Prodromal Burden Than Those Without Such a History
Objective: To characterise prodromal presentation in neurologically healthy individuals with and without a history of traumatic brain injury (TBI), compared to those with clinically diagnosed…AI-Driven Prediction Models for Advanced Parkinson’s Disease: A Data-Driven Approach Using PPMI and CDEPA Criteria
Objective: To develop machine learning models that predict advanced Parkinson’s disease (APD) by integrating quantitative clinical data from the Parkinson’s Progression Markers Initiative (PPMI) with…Pilot Feasibility Data using Augmented Reality and Machine Learning-Based Digital Cognitive Assessment in Parkinson’s disease
Objective: To assess the feasibility of using a novel cognitive and functional digital biomarker assessment, the Altoida NeuroMarker platform, to evaluate the presence of MCI…Evaluation Of Diagnostic Latency In Parkinson’s Disease Based On Non-Motor Symptoms Subtype
Objective: To identify the non-motor symptom (NMS) subtype associated with diagnostic latency (DL) in people living with Parkinson Disease (PwP). Background: The NMS subtypes have…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 55
- Next Page »